Notably, parity has been identified as a predisposing factor, rendering breasts susceptible to the oncogenic effects of PAPP-A, thereby implying that pregnancy-related factors may modulate PAPP-A's role in breast cancer development [25]. The gene discussed is PAPPA; the disease is breast cancer.